Search
forLearn
5 / 801 resultslearn Scalp Micropigmentation
scalp tattoos to mimic the appearance of light stubble
learn Tofacitinib
a JAK inhibitor for alopecia areata and other autoimmune conditions
learn Keracyn
learn retinoic acid
Research
5 / 1000+ results
research Correspondence
RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.
research Dermatopathia pigmentosa reticularis: A rare reticulate pigmentary disorder
Dermatopathia pigmentosa reticularis causes skin discoloration, hair loss, and nail problems.
research Teaching dermatosurgery
Dermatology residents need thorough training in dermatosurgery for better patient outcomes.
research Index
The document is a detailed guide on skin conditions and treatments for dermatologists.
research Index
The document is a detailed medical reference on skin and genetic disorders.
Community Join
5 / 1000+ resultscommunity Anyone tried Thicair? thoughts?
Thicair is a product combining microneedling and subdural vitamins for hair loss, containing ingredients like Panax Ginseng Root Extract and Copper Tripeptide-1. Users are skeptical, with one calling it "quackery."
community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China
The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.
community Using minoxidil for 6 months. Not seeing results
Minoxidil alone is not effective for hair regrowth; adding a DHT blocker like finasteride or dutasteride is recommended. Dermastamping and micro-needling can enhance results, and some users suggest trying oral minoxidil or natural DHT blockers.
community Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US_Kintor Pharmaceutical Limited
Kintor Pharma finished enrolling and dosing participants in a Phase I trial for a hair loss treatment called AR-PROTAC (GT20029). The effectiveness of another drug, pyrilutamide (KX-826), for hair loss will be clearer after a Phase 2 trial expected to complete in January 2023.
community Kintor pyrilutamide presentation?
The conversation is about whether the phase 2 results for pyrilutamide, a potential hair loss treatment, were presented at a dermatology convention and inquiries about the completion of phase 3 trials. Specific treatments mentioned include pyrilutamide.